WO2002097036A3 - Compositions and methods for adipose abundant protein - Google Patents

Compositions and methods for adipose abundant protein Download PDF

Info

Publication number
WO2002097036A3
WO2002097036A3 PCT/US2002/016497 US0216497W WO02097036A3 WO 2002097036 A3 WO2002097036 A3 WO 2002097036A3 US 0216497 W US0216497 W US 0216497W WO 02097036 A3 WO02097036 A3 WO 02097036A3
Authority
WO
WIPO (PCT)
Prior art keywords
adipose
compositions
methods
abundant protein
sequence
Prior art date
Application number
PCT/US2002/016497
Other languages
French (fr)
Other versions
WO2002097036A2 (en
Inventor
Sean H Adams
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Priority to AU2002312047A priority Critical patent/AU2002312047A1/en
Publication of WO2002097036A2 publication Critical patent/WO2002097036A2/en
Publication of WO2002097036A3 publication Critical patent/WO2002097036A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

An isolated polypeptide comprising an amino acid sequence having at least 80% sequence identity to the sequence SEQ ID NOS:4 or 6, polynucleotides encoding these peptides, and antibodies to the polypeptides are useful in treating metabolic disorders or disorders associated with changes in adipose tissue physiological function or mass.
PCT/US2002/016497 2001-05-25 2002-05-24 Compositions and methods for adipose abundant protein WO2002097036A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002312047A AU2002312047A1 (en) 2001-05-25 2002-05-24 Compositions and methods for adipose abundant protein

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29374101P 2001-05-25 2001-05-25
US60/293,741 2001-05-25

Publications (2)

Publication Number Publication Date
WO2002097036A2 WO2002097036A2 (en) 2002-12-05
WO2002097036A3 true WO2002097036A3 (en) 2005-07-28

Family

ID=23130381

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/016497 WO2002097036A2 (en) 2001-05-25 2002-05-24 Compositions and methods for adipose abundant protein

Country Status (2)

Country Link
AU (1) AU2002312047A1 (en)
WO (1) WO2002097036A2 (en)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KONISHI ET AL: "Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at distal 17p13.3 in human lung cancer", ONCOGENE, vol. 22, no. 12, 27 March 2003 (2003-03-27), pages 1892 - 1905, XP002978724 *

Also Published As

Publication number Publication date
AU2002312047A1 (en) 2002-12-09
AU2002312047A8 (en) 2005-11-17
WO2002097036A2 (en) 2002-12-05

Similar Documents

Publication Publication Date Title
AU4778101A (en) Novel polypeptides, and nucleic acids encoding the same
NZ504548A (en) Polypeptides and nucleic acids encoding human chordin
WO2007002261A3 (en) IL-1β BINDING ANTIBODIES AND FRAGMENTS THEREOF
EP2258383A3 (en) Antigenic peptides derived from telomerase
ZA9810679B (en) Antimicrobial peptides.
WO2001005422A3 (en) Use of a polypeptide for detecting, preventing or treating a pathological condition associated with a degenerative, neurological or autoimmune disease
ATE342359T1 (en) DESIGN OF BETA-SHEET PROTEINS WITH SPECIFIC BINDING PROPERTIES
WO2000075173A3 (en) Peptide fragments of colostrinin
WO1999060017A3 (en) Human tumour-derived polypeptide hormone phosphatonin
WO2004014937A3 (en) Thrombin peptide derivatives
WO2004005317A3 (en) Thrombin peptide derivative dimers
ZA200006309B (en) A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof.
WO2001098355A3 (en) Cgi-69 compositions and methods of use
ATE357526T1 (en) MODIFIED HCV PEPTIDE VACCINES
EP1443055A3 (en) Interleukins-21 and 22
IL134436A0 (en) Neisseria lactoferrin binding protein
WO1999051188A3 (en) A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
AU2676399A (en) Novel cystine knot protein and materials and methods for making it
WO2002097036A3 (en) Compositions and methods for adipose abundant protein
WO2002096355A3 (en) Compositions and methods for adipose abundant protein
WO2001032878A3 (en) A novel polypeptide hormone phosphatonin
CA2163805A1 (en) Novel activating factor of leukocytes
WO2001070808A3 (en) Angiogenesis - associated proteins, and nucleic acids encoding the same
WO2003031566A3 (en) Keratinocyte derived interferon
WO2003044159A9 (en) Zinc finger proteins, polynucleotides encoding same and antibodies thereto

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP